Alan Whittle

Title: Alan Whittle: Innovator in Protein Kinase Inhibitors

Introduction

Alan Whittle is a notable inventor based in Bridgerule, Devon, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as protein kinase inhibitors. His work is crucial in the fight against various illnesses, including cancer.

Latest Patents

Alan Whittle holds a patent for "7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors." This patent encompasses the compounds of formula I, their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers, and racemates. The invention details the preparation of these compounds, the medicaments containing them, and their application in controlling or preventing diseases such as cancer.

Career Highlights

Alan Whittle is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to focus on innovative solutions in drug development. His expertise in medicinal chemistry has positioned him as a valuable asset in the research and development of new therapeutic agents.

Collaborations

Throughout his career, Alan has collaborated with notable colleagues, including Konrad Honold and Jane Paul. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in medicinal research.

Conclusion

Alan Whittle's contributions to the field of protein kinase inhibitors highlight his dedication to advancing medical science. His innovative work continues to play a vital role in the development of treatments for serious illnesses.